|
1
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
2
|
Yu Z, Pestell TG, Lisanti MP and Pestell
RG: Cancer stem cells. Int J Biochem Cell Biol. 44:2144–2151. 2012.
View Article : Google Scholar
|
|
3
|
Neumüller RA and Knoblich JA: Dividing
cellular asymmetry: asymmetric cell division and its implications
for stem cells and cancer. Genes Dev. 23:2675–2699. 2009.PubMed/NCBI
|
|
4
|
La Porta CA: Mechanism of drug sensitivity
and resistance in melanoma. Curr Cancer Drug Targets. 9:391–397.
2009.PubMed/NCBI
|
|
5
|
Yin G, Alvero AB, Craveiro V, Holmberg JC,
Fu HH, Montagna MK, Yang Y, Chefetz-Menaker I, Nuti S, Rossi M,
Silasi DA, Rutherford T and Mor G: Constitutive proteasomal
degradation of TWIST-1 in epithelial-ovarian cancer stem cells
impacts differentiation and metastatic potential. Oncogene.
32:39–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hurt EM, Chan K, Serrat MA, Thomas SB,
Veenstra TD and Farrar WL: Identification of vitronectin as an
extrinsic inducer of cancer stem cell differentiation and tumor
formation. Stem Cells. 28:390–398. 2010.PubMed/NCBI
|
|
7
|
Robertson FM, Ogasawara MA, Ye Z, Chu K,
Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M and
Barsky SH: Imaging and analysis of 3D tumor spheroids enriched for
a cancer stem cell phenotype. J Biomol Screen. 15:820–829. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vinci M, Gowan S, Boxall F, Patterson L,
Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D and Eccles
SA: Advances in establishment and analysis of three-dimensional
tumor spheroid-based functional assays for target validation and
drug evaluation. BMC Biol. 10:292012. View Article : Google Scholar
|
|
9
|
Ayla S, Bilir A, Soner BC, Yilmaz-Dilsiz
O, Ergüven M and Oktem G: Notch signaling-related therapeutic
strategies with novel drugs in neuroblastoma spheroids. J Pediatr
Hematol Oncol. 36:37–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diaz JA and Murillo MF: Phenotype
characterization of embryoid body structures generated by a crystal
comet effect tail in an intercellular cancer collision scenario.
Cancer Manag Res. 4:9–21. 2012. View Article : Google Scholar
|
|
11
|
Gaedtke L, Thoenes L, Culmsee C, Mayer B
and Wagner E: Proteomic analysis reveals differences in protein
expression in spheroid versus monolayer cultures of low-passage
colon carcinoma cells. J Proteome Res. 6:4111–4118. 2007.
View Article : Google Scholar
|
|
12
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24−/low/CD44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006.PubMed/NCBI
|
|
13
|
Oktem G, Bilir A, Ayla S, Yavasoglu A,
Goksel G, Saydam G and Uysal A: Role of intercellular
communications in breast cancer multicellular tumor spheroids after
chemotherapy. Oncol Res. 16:225–233. 2006.PubMed/NCBI
|
|
14
|
Oktem G, Bilir A, Selvi N, Yurtseven ME,
Vatansever S, Ates U, Uysal A and Omay SB: Chemotherapy influences
inducible nitric oxide synthase (iNOS) and endothelial nitric oxide
synthase (eNOS) activity on 3D breast cancer cell line. Oncol Res.
16:195–203. 2006.PubMed/NCBI
|
|
15
|
Edwards IJ: Proteoglycans in prostate
cancer. Nat Rev Urol. 9:196–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ricciardelli C, Sakko AJ, Ween MP, Russell
DL and Horsfall DJ: The biological role and regulation of versican
levels in cancer. Cancer Metastasis Rev. 28:233–245. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakko AJ, Ricciardelli C, Mayne K, Suwiwat
S, LeBaron RG, Marshall VR, Tilley WD and Horsfall DJ: Modulation
of prostate cancer cell attachment to matrix by versican. Cancer
Res. 63:4786–4791. 2003.PubMed/NCBI
|
|
18
|
Ricciardelli C, Russell DL, Ween MP, Mayne
K, Suwiwat S, Byers S, Marshall VR, Tilley WD and Horsfall DJ:
Formation of hyaluronan- and versican-rich pericellular matrix by
prostate cancer cells promotes cell motility. J Biol Chem.
282:10814–10825. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ween MP, Hummitzsch K, Rodgers RJ, Oehler
MK and Ricciardelli C: Versican induces a pro-metastatic ovarian
cancer cell behavior which can be inhibited by small hyaluronan
oligosaccharides. Clin Exp Metastasis. 28:113–125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakko AJ, Ricciardelli C, Mayne K, Tilley
WD, Lebaron RG and Horsfall DJ: Versican accumulation in human
prostatic fibroblast cultures is enhanced by prostate cancer
cell-derived transforming growth factor β1. Cancer Res. 61:926–930.
2001.PubMed/NCBI
|
|
21
|
Cross NA, Chandrasekharan S, Jokonya N,
Fowles A, Hamdy FC, Buttle DJ and Eaton CL: The expression and
regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFβ1 in
prostate cells: relevance to the accumulation of versican.
Prostate. 63:269–275. 2005.PubMed/NCBI
|
|
22
|
Knaup J, Gruber C, Krammer B, Ziegler V,
Bauer J and Verwanger T: TGFβ-signaling in squamous cell carcinoma
occurring in recessive dystrophic epidermolysis bullosa. Anal Cell
Pathol. 34:339–353. 2011.
|
|
23
|
Ryynänen M, Knowlton RG, Parente MG, Chung
LC, Chu ML and Uitto J: Human type VII collagen: genetic linkage of
the gene (COL7A1) on chromosome 3 to dominant dystrophic
epidermolysis bullosa. Am J Hum Genet. 49:797–803. 1991.PubMed/NCBI
|
|
24
|
Switala-Jelen K, Dabrowska K, Opolski A,
Lipinska L, Nowaczyk M and Gorski A: The biological functions of β3
integrins. Folia Biol. 50:143–152. 2004.
|
|
25
|
Hood JD and Cheresh DA: Role of integrins
in cell invasion and migration. Nat Rev Cancer. 2:91–100. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hieken TJ, Farolan M, Ronan SG, Shilkaitis
A, Wild L and Das Gupta TK: β3 integrin expression in melanoma
predicts subsequent metastasis. J Surg Res. 63:169–173. 1996.
|
|
27
|
Vacca A, Ria R, Presta M, Ribatti D,
Iurlaro M, Merchionne F, Tanghetti E and Dammacco F:
αvβ3 integrin engagement modulates cell
adhesion, proliferation, and protease secretion in human lymphoid
tumor cells. Exp Hematol. 29:993–1003. 2001.
|
|
28
|
Rentala S, Yalavarthy PD and Mangamoori
LN: α1 and β1 integrins enhance the homing and differentiation of
cultured prostate cancer stem cells. Asian J Androl. 12:548–555.
2010.
|
|
29
|
Sagar BM, Rentala S, Gopal PN, Sharma S
and Mukhopadhyay A: Fibronectin and laminin enhance engraftibility
of cultured hematopoietic stem cells. Biochem Biophys Res Commun.
350:1000–1005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lo PK, Kanojia D, Liu X, Singh UP, Berger
FG, Wang Q and Chen H: CD49f and CD61 identify Her2/neu-induced
mammary tumor-initiating cells that are potentially derived from
luminal progenitors and maintained by the integrin-TGFβ signaling.
Oncogene. 31:2614–2626. 2012.PubMed/NCBI
|
|
31
|
Pytliak M, Vargová V and Mechírová V:
Matrix metalloproteinases and their role in oncogenesis: a review.
Onkologie. 35:49–53. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inoue A, Takahashi H, Harada H, Kohno S,
Ohue S, Kobayashi K, Yano H, Tanaka J and Ohnishi T: Cancer
stem-like cells of glioblastoma characteristically express MMP-13
and display highly invasive activity. Int J Oncol. 37:1121–1131.
2010.PubMed/NCBI
|
|
33
|
Barami K: Relationship of neural stem
cells with their vascular niche: implications in the malignant
progression of gliomas. J Clin Neurosci. 15:1193–1197. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Calabrese C, Poppleton H, Kocak M, Hogg
TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M,
Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A and
Gilbertson RJ: A perivascular niche for brain tumor stem cells.
Cancer Cell. 11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Astarci E, Erson-Bensan AE and Banerjee S:
Matrix metalloprotease 16 expression is downregulated by
microRNA-146a in spontaneously differentiating Caco-2 cells.
Dev Growth Differ. 54:216–226. 2012.PubMed/NCBI
|
